[AXI Select] Prop Trading Journal: Bitcoin Short Position Closes in Profit! (May 20, 2026)
Hi everyone, this is Chartinfo. Here is my trading log for Phase 1 of the Axi Select prop trading challenge.
We've successfully met the initial requirements for Axi Select and advanced to Phase 1. Currently, we are trading with $4,500 in funded capital.
If you're interested in prop trading, I can confidently tell you that Axi Select is way better than prop firms like APEX!
📊 Trade Analysis: BTCUSD (Bitcoin)
For this entry, I noticed Bitcoin failed to break its previous high according to Dow Theory. Anticipating disappointed longs to sell off, I decided to take a short position.
Position: Short
Confluence: Dow Theory, Resistance, Economic Indicators
📍 Trading Details
Entry Price: 80,342.28
Stop Loss: 82,300 (previous high)
Target Price: 76,500
Take Profit: 79,217
Risk Management: Set at 2% of account equity
✅ Trade Outcome & Review
Realized Profit: +11.25 USD (2% profit)
Execution Price: 80,342.28
👍 What went well: Having the courage to short the pump driven by the Clarity Act news.
🤔 Room for improvement: The entry was solid, but my take-profit timing was way too early. Knowing when to exit is a skill in itself, and I definitely need to work on this. The lack of a scale-out strategy (partial take profit) also played a major role.
🚩 AXI Select Challenge Status
Current Stage: Phase 1 (Seed Stage in progress)
Account Balance: 521.37 USD
Remaining Tasks: 20 minimum trades required (Currently 8/20 completed)
Goal Achievement Rate: 25%
Smooth sailing towards the $20,000 Incubation stage!
Ready to start your own Axi Select prop trading journey? Sign up now!
Trade with Axi—the global broker with the lowest fees—and get a 90% rebate back on your trades!
Chartinfo - CFD Rebate provider
Every trade you make without a rebate is a missed profit. Chartinfo is a trusted CFD rebate provider dedicated to maximizing your returns through seamless cashback solutions. Click here to visit our website and start earning today!
Comments
Post a Comment